a numerical trendp=0.400
PAC use was not significantly associated with survival in this study, despite a numerical trend toward better outcome (p=0.400, Table 5 , Figure S4 ).
PAC use was not significantly associated with survival in this study, despite a numerical trend toward better outcome (p=0.400, Table 5 , Figure S4 ).
Additionally, variations in baseline characteristics and shock profiles over time could have influenced patient survival, even though these variations did not reach statistical significance.
A suggestive trend of improving 30‐day survival was observed (56.8%, 63.9%, and 72.2% in successive one thirds, P1, P2, and P3 of patients), paralleling a similar trend in achievement of best practices.